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Introduction:While pain in multiple sclerosis (MS) is common, in many cases the precise mechanisms are un-
clear. Neuroimaging studies could have a valuable role in investigating the aetiology of pain syndromes. The
aim of this review was to synthesise and appraise the current literature on neuroimaging studies of pain syn-
dromes in MS.
Methods:We systematically searched PubMed and Scopus from their inception dates to the 2nd of April 2013.
Studies were selected by predeﬁned inclusion and exclusion criteria. Methodological quality was appraised. De-
scriptive statistical analysis was conducted.
Results: We identiﬁed 38 studies of variable methodology and quality. All studies but one used conventional
structural magnetic resonance imaging, and themajority reported a positive association between location of de-
myelinating lesions and speciﬁc neuropathic pain syndromes. Most investigated headache and facial pain, with
more common pain syndromes such as limbpain being relatively understudied.We identiﬁed a number ofmeth-
odological concerns, which along with variable study design and reporting limit our ability to synthesise data.
Higher quality studies were however less likely to report positive associations of lesion distribution to pain syn-
dromes.
Conclusions: Further high quality hypothesis-driven neuroimaging studies of pain syndromes inMS are required
to clarify pain mechanisms, particularly for the commonest pain syndromes.
© 2014 . The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Multiple sclerosis (MS) is an inﬂammatory disease of the central ner-
vous system (CNS), which is associated with demyelination and neuro-
degeneration (Compston and Coles, 2008). Pain has been recognised as
a symptom of MS since the ﬁrst descriptions of the disease (Charcot,
1872) and can broadly be classiﬁed as nociceptive or neuropathic
(O3Connor et al., 2008). It is common – the overall point prevalence of
pain in MS is around 50% (O3Connor et al., 2008) – and it is often ranked
by patients as one of themost distressing symptoms of the disease (Kalia
and O3Connor, 2005). In spite of the prevalence and clinical importance
of pain in MS, its mechanisms remain poorly understood.
Magnetic resonance imaging (MRI) plays a crucial role both in the
diagnosis of MS (Polman et al., 2011) and in clinical research
applications. It is widely used to study both inﬂammatory lesions and
non-lesional tissue changes in vivo (Bakshi et al., 2008). MRI is also an
important tool in the study of pain mechanisms, and it is likely to play
an increasing clinical role in the future (Wise and Tracey, 2006).
Positron-emission tomography (PET) and single-photon emission-
computed tomography (SPECT) have, in addition, proved invaluable in
the study of neurotransmitter systems involved in pain.
While neuroimaging is separately established as amainstay in the in-
vestigation of both MS and pain, the study of pain syndromes in MS by
neuroimaging remains a developing ﬁeld. Improved understanding of
neuroradiological ﬁndings in MS pain could improve our understanding
of itsmechanisms, and in turn contribute to development of therapies. In
order to identify gaps in knowledge, and highlight future research prior-
ities, our review summarises and appraises existing studies of neuroim-
aging correlates of MS pain (using MRI, PET or SPECT) and assesses the
neuroradiological evidence for aetiology of MS-related pain syndromes.Fig. 1. Flow diagram of the review procedure.2. Materials and methods
Our primary outcome of interest was the radiological evidence for
the aetiology of any pain syndrome in MS. We analysed ﬁndings of
available studies in light of detailed methodological assessment and
emphasised results of high quality hypothesis-driven studies.We antic-
ipated a low number of available studies, and therefore included any
pain syndrome described as associated with MS.
We searched PubMed and Scopus from their inception dates (1977
and 1960, respectively) to the 2nd of April 2013. Keywords used for the
PubMed search included the medical subject heading (MeSH) terms
“pain” and “multiple sclerosis” alongwith “magnetic resonance imaging”
or “positron-emission tomography” or “tomography, emission-
computed, single-photon”. Keywordsused for the Scopus search included
all entry terms of eachMeSH term in PubMed and theMeSH terms them-
selves, combined in the same manner. We also hand-searched reference
lists and consulted experts in the ﬁeld to identify additional material.
We included all original English language studies examining neuro-
imaging correlates of pain inMS – usingMRI, PET or SPECT imaging – in
human adults. Three studies were excluded by the language criterion.
We also excluded paediatric studies, studies of other demyelinating dis-
orders, re-published data, and review articles.
We reviewed the titles and abstracts of identiﬁed studies and exclud-
ed duplicate references. Two reviewers (DS, PF) independently reviewed
potentially relevant articles. Disagreements were resolved by consensus.
We then assessed quality of studies using the following 12 criteria
relevant to our review objectives (adapted from Campbell et al.,2011): clearly stated research objective, recruitment procedure, and in-
clusion/exclusion criteria; description of sample demographics, partici-
pation rates, imaging protocol, and pain measurement instruments;
image interpretation carried out without knowledge of subjects3 pain
status; participation rate above 70%; use of multivariate analysis;
reporting of strength of effect, and acknowledgment of study limita-
tions. Given the low number of identiﬁed studies, we did not exclude
any studies on the basis of quality assessment. We also assessed the
reporting of imaging methodology, clinical diagnostic criteria used, re-
ported imagingﬁndings, andmethods used to investigate links between
radiological ﬁndings and occurrence of pain syndromes. We conducted
descriptive statistical analysis. We identiﬁed studies as case reports,
case series, or investigational studies (deﬁned here by any study with
hypothesis-driven experimental design). This work was not submitted
to an ethics committee because it is a systematic reviewof the literature.
3. Results
We found 902 candidate publications (Fig. 1). Thirty-eight met the
inclusion criteria (Alstadhaug et al., 2008; Andrade et al., 2012;
Athanasiou et al., 2005; Balasa and Bajko, 2010; Bentley et al., 2002;
Broggi et al., 2004; Burkey and Abla-Yao, 2010; Carrieri et al., 2009;
Cordella et al., 2009; Cruccu et al., 2009; da Silva et al., 2005; Davey
and Al-Din, 2004; Deppe et al., 2013; de Santi et al., 2009; Donat,
Table 1
Characteristics of included investigational studies.
Author
(year)
Country Type of study Study population (n=) Main study focus Assessment of pain Imaging Main ﬁndings
Balasa (2010) Romania Retrospective,
cross-sectional
20 patients with TN (10 with
MS and 10 without MS)
Evaluation of clinical differences
in TN presentation and
pharmacological treatment re-
sponse
in patients with and without MS
International Headache Society
Classiﬁcation (2004), Barrow
Neurological Institute score of
clinical pain intensity
MRI (1 T o image acquisition
or readin protocols deﬁned
MS patients had earlier onset TN,
probably secondary to lesions in
the trigeminal pathways, with
overlapping characteristics and
treatment response when compared
to non-MS TN
Cruccu (2009) Italy Retrospective,
cross-sectional
130MS patients (50with TN, 30
with sensory trigeminal distur-
bances, and 50 controls)
Causes and mechanisms of MS-
related TN
International Headache Society
Classiﬁcation (2004),
neurological examination
including sensory and
trigeminal reﬂex testing
MRI, ded ted image acquisition
protocol lthoughnot speciﬁed),
voxel-ba d brainstem analysis,
read by uroradiologists
The onset ages of MS and trigeminal
symptoms were older in the
TN group, and most patients in the
TN and non-TN groups had
abnormal trigeminal reﬂexes. In the
TN group the highest probability of
brainstem lesion was in the pontine
trigeminal primary afferents
Deppe (2013) Germany Retrospective 1 MS patient and 100 healthy
controls
Investigate diffusion tensor
imaging abnormalities in the
thalamus related to a central
pain syndrome comparing with
controls
Describes the pain syndrome
only
as “episode of central pain and
abnormal somatosensory and
thermal sensations on the right
hand side of the body”
MRI (3 T ell described imaging
protocol d post-processing,
data
was obta ed from a pilot study
for
a clinical ial, ROI analysis of the
thalami
Temporary increase of the
fractional anisotropy in the
thalamus contralateral to the
pain; a causative role is suggested
Gee (2005) United
States of
America
Retrospective,
cross-sectional
277 MS patients To determine if the prevalence
of migraine-like headache in
MS patients was associated
with plaques in the brainstem
or other locations
International Headache Society
Classiﬁcation (1988), tailored
questionnaire
MRI, con dictory information
regardin mage acquisition
protocol eld strength and
scanners redeﬁned reading
protocol
The presence of a midbrain
plaque was associated with an
increased likelihood of headache
with migraine characteristics;
lesions in other locations and
lesion load were not associated
with headache prevalence
Kister (2010) United
States of
America
Cross-sectional 204 MS patients To assess the relative frequency
of migraine in MS and to
compare clinical and radiographic
characteristics in MS patients
with and without migraine
International Headache Society
Classiﬁcation (2004), tailored
questionnaire to characterise
headache and comorbidities
adapted
from the American Migraine
Prevalence and Prevention
Study,
migraine severity assessed
with
Migraine Disability Assessment
tool
MRI (0.6, 5 and 3 T), image
acquisiti protocol deﬁned (T2-
w
and pre- d post-contrast T1-
w),
images r d by a neurologist and
an
expert in S neuroradiology
Migraine frequency was threefold
higher in MS patients than in
controls, and was more
symptomatic; no difference in number
or distribution of plaques, or
enhancing lesions between
migraine and no-migraine groups
Ramirez-Lassepas (1992) United
States of
America
Retrospective,
cross-sectional
11 MS patients To study radicular pain as
presenting MS symptom
– Myelogra y, computed
tomograp or MRI; no image
acquisitio or reading protocols
deﬁned
Acute radicular pain in the absence
of demonstrable root compression
may not be an uncommon
presenting symptom in MS and
may be associated with trauma; in
two patients plaques in the spinal
cord explained the symptoms
324
D
.Seixas
etal./N
euroIm
age:Clinical5
(2014)
322
–331), n
g
ica
(a
se
ne
), w
an
in
tr
tra
g i
, ﬁ
; p
1.
on
an
ea
M
ph
hy
n
Author
(year)
Country Type of
study
Study population
(n=)
Main study focus Assessment of pain Imaging Main ﬁndings
Svendsen (2011) Denmark Cross-sectional 25 MS patients with sensory
disturbances (13 with pain and
12 without pain)
To study location of plaques in MS
patients with sensory disturbances
with and without pain, and to as-
certain if deafferentiation of
spinothalamic tract was more com-
mon in the patients with pain
Structured pain interview, pain
location in body map,
neurological examination
including bedside sensory
examination
MRI (1.5 T), image acquisition
protocol deﬁned (brain — sagittal
T1-w and T2-w and axial FLAIR,
spine — sagittal T1-w and STIR
axial T2-w), read by a neuroradi-
ologist according to deﬁned read-
ing protocol
No association between central pain
and site of demyelination was found;
central pain was associated with
allodynia, suggesting central
hyperexcitability
Tortorella (2006) Italy Retrospective 58 patients with migraine and
79 MS patients (37 with and 42
without migraine)
Evaluate if red nucleus, substantia
nigra and periaqueductal grey
matter were involved by MRI-
detectable structural abnormalities
in migraine patients, and to investi-
gate their frequency and extent in
MS patients with migraine
International Headache Society
Classiﬁcation (2004)
MRI (1.5 T), deﬁned image
acquisition protocol (axial PD/T2-
w), read by two observers using a
deﬁned reading protocol
Brainstem lesions were frequent in
non-MS migraine, but did not seem
associated with aura; demyelinating
lesions in the red nucleus, substantia
nigra and periaqueductal grey matter
might be among the factors responsi-
ble for migraine in MS
Broggi (2004) Italy Cross-sectional,
prospective
35 MS patients who underwent
MVD for TN
To clarify the role of MVD in the
treatment of TN in MS
Post-operative presence and
intensity of residual facial pain
and subsequent treatment for
TN
MRI (0.5 or 1.5 T), deﬁned image
acquisition protocol (axial PD/T2-
w, axial or coronal FLAIR; in 23
patients additional axial T2-w or
coronal T2-w thin slices, coronal
T1-w post-contrast, and 3D TOF
angiography)
Results of MVD in TN in MS seemed to
be less satisfactory than in the idio-
pathic group, suggesting a central
mechanism in MS TN
da Silva (2005) Brazil Retrospective,
cross-sectional
275 MS patients Review of incidence of trigeminal
involvement on MRI, as well as clin-
ical correlation in patients with MS
Search for trigeminal symptoms
in medical records and medical
attendances
MRI (1 T), deﬁned image
acquisition protocol (axial FLAIR,
PD/T2-w, and T1-w before and
after contrast)
High clinically silent incidence of
trigeminal involvement in MS, includ-
ing simultaneous central and periph-
eral demyelination
Gass (1997) UK and
Germany
Cross-sectional? 6 MS patients with TN Lesion localisation in MS patients
with TN
Neurological examination MRI (1.5 T), deﬁned image
acquisition protocol (including
axial PD/T2-w)
Brainstem lesions involving the
trigeminal ﬁbres were demonstrated,
without neurovascular contacts
Yetimalar (2008) Turkey Retrospective,
cross-sectional
21 MS patients (11 with pain
syndromes including headache,
brachalgia and throat pain)
Description of patients with unusual
symptoms that were primary
manifestations of MS
International Headache Society
Classiﬁcation (2004),
neurological examination
MRI (1.5 T), use of contrast Possible correlations between clinical
disturbances and neuroradiological
abnormalities of some unusual primary
manifestations of MS
Eldridge (2003) UK Retrospective 9 MS patients with TN To assess whether MVD was a safe
and efﬁcacious treatment for pa-
tients with TN and MS
Review of medical records MRI (1.5 T), protocol deﬁned
(conventional MRI and angiogra-
phy, with and without contrast)
MVD provided good initial pain relief,
but recurrence rate was higher than in
idiopathic TN
MS —multiple sclerosis; TN — trigeminal neuralgia; MRI —magnetic resonance imaging; MVD —microvascular decompression; T — tesla; T1-w — T1-weighted; T2-w — T2-weighted; PD — proton density; FLAIR— ﬂuid attenuation inversion re-
covery; STIR — short T1 inversion recovery; TOF— time-of-ﬂight.
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326 D. Seixas et al. / NeuroImage: Clinical 5 (2014) 322–3312012; Eldridge et al., 2003; Fragoso and Brooks, 2007; Gass et al., 1997;
Gee et al., 2005; Gentile et al., 2007; González-Quintanilla et al., 2012;
Haas et al., 1993; Hellwig et al., 2006; Kister et al., 2010; Leandri et al.,
1999; Liu et al., 2008; Marchettini et al., 2006; Meaney et al., 1995;
Minagar and Sheremata, 2000; Nakashima et al., 2001; Pichiecchio
et al., 2007; Ramirez-Lassepas et al., 1992; Svendsen et al., 2011; Tanei
et al., 2010; Tortorella et al., 2006; Tosi et al., 1998; Vilisaar and
Constantinescu, 2006; Yetimalar et al., 2008). Of these, 16 were case re-
ports (Alstadhaug et al., 2008; Andrade et al., 2012; Bentley et al., 2002;
Burkey and Abla-Yao, 2010; Carrieri et al., 2009; Davey and Al-Din,
2004; Donat, 2012; Gentile et al., 2007; González-Quintanilla et al.,
2012; Haas et al., 1993; Leandri et al., 1999; Liu et al., 2008;
Pichiecchio et al., 2007; Tanei et al., 2010; Tosi et al., 1998; Vilisaar
and Constantinescu, 2006), nine were case series (Athanasiou et al.,
2005; Cordella et al., 2009; de Santi et al., 2009; Fragoso and Brooks,
2007; Hellwig et al., 2006; Marchettini et al., 2006; Meaney et al.,
1995; Minagar and Sheremata, 2000; Nakashima et al., 2001), and 13
were investigational studies (Balasa and Bajko, 2010; Broggi et al.,
2004; Cruccu et al., 2009; da Silva et al., 2005; Deppe et al., 2013;
Eldridge et al., 2003; Gass et al., 1997; Gee et al., 2005; Kister et al.,
2010; Ramirez-Lassepas et al., 1992; Svendsen et al., 2011; Tortorella
et al., 2006; Yetimalar et al., 2008). Characteristics of included investiga-
tional studies are detailed in Table 1. On quality assessment, the mean
number of criteria fulﬁlled by the included investigational studies
(n = 13) was six (range 3–12). Only Kister et al. (2010) fulﬁlled all
the criteria. Four studies (Gee et al., 2005; Kister et al., 2010; Svendsen
et al., 2011; Tortorella et al., 2006) fulﬁlled seven or more of the twelve
criteria (Table 2).
3.1. Reporting of image acquisition methods
All identiﬁed studies used conventional structural MRI but one,
which investigated pain in MS using diffusion tensor imaging (DTI)
(Deppe et al., 2013). No studies used functional MRI, SPECT or PET.
There were signiﬁcant deﬁciencies in the description of imaging meth-
odology in many studies (Table 3 summarises frequency of description
of each aspect of imaging acquisition). We found that ﬁeld strengthwas
speciﬁed in 15 studies (39% of all studies). Of these 15 studies, one tesla
scanners were used in two studies (Balasa and Bajko, 2010; da Silva
et al., 2005), 1.5 T scanners were used in nine studies (Eldridge et al.,
2003; Gass et al., 1997; Gee et al., 2005; Meaney et al., 1995;
Nakashima et al., 2001; Pichiecchio et al., 2007; Svendsen et al., 2011;
Tortorella et al., 2006; Yetimalar et al., 2008), and 3 T scanners were
used in two (of the most recent) studies (Andrade et al., 2012; Deppe
et al., 2013). Scanners of varying strengths were employed in two stud-
ies: 0.6, 1.5 and 3 T (Kister et al., 2010), and 0.5 and 1.5 T (Broggi et al.,
2004). Of all the included studies, MRI protocols were stated only in 14
(37%) (Andrade et al., 2012; Athanasiou et al., 2005; Broggi et al., 2004;
da Silva et al., 2005; Deppe et al., 2013; Donat, 2012; Eldridge et al.,
2003; Gass et al., 1997; González-Quintanilla et al., 2012; Haas et al.,
1993; Kister et al., 2010; Meaney et al., 1995; Svendsen et al., 2011;
Tortorella et al., 2006). Of the 14 studies that did describe the MRI pro-
tocol used, only nine of these described all the sequences (Broggi et al.,
2004; da Silva et al., 2005; Deppe et al., 2013; Gass et al., 1997; Haas
et al., 1993; Kister et al., 2010; Meaney et al., 1995; Svendsen et al.,
2011; Tortorella et al., 2006), and only four described all the sequence
parameters of all the sequences (da Silva et al., 2005; Gass et al., 1997;
Svendsen et al., 2011; Tortorella et al., 2006). Imaging methodology
was relatively better described in the 13 investigational studies, al-
though four did not describe MRI protocols, and reading methods
were described in only ﬁve studies.
3.2. Diagnosis of multiple sclerosis
Criteria used to conﬁrm the diagnosis of MSwere explicitly stated in
only 16 of the 38 studies (2010 revisions to the McDonald criteria —Polman et al., 2011 (Deppe et al., 2013; González-Quintanilla et al.,
2012); revised McDonald — Polman et al., 2005 (Andrade et al., 2012;
Cruccu et al., 2009; Fragoso and Brooks, 2007; Gentile et al., 2007;
Kister et al., 2010); McDonald — McDonald et al., 2001 (Balasa and
Bajko, 2010; Carrieri et al., 2009; Hellwig et al., 2006; Yetimalar et al.,
2008); Poser — Poser et al., 1983 (Broggi et al., 2004; Hellwig et al.,
2006; Leandri et al., 1999; Meaney et al., 1995); Rose — Rose et al.,
1976 (Ramirez-Lassepas et al., 1992)). The type of MS in subjects was
not fully described in 14 studies (Athanasiou et al., 2005; Balasa and
Bajko 2010; Burkey and Abla-Yao, 2010; Cruccu et al., 2009; Donat,
2012; Eldridge et al., 2003; Fragoso and Brooks, 2007; González-
Quintanilla et al., 2012; Kister et al., 2010; Marchettini et al., 2006;
Meaney et al., 1995; Minagar and Sheremata, 2000; Ramirez-Lassepas
et al., 1992; Yetimalar et al., 2008). It was relapsing–remitting in 16
((Alstadhaug et al., 2008; Andrade et al., 2012; Bentley et al., 2002;
Carrieri et al., 2009; Deppe et al., 2013; de Santi et al., 2009; Gentile
et al., 2007; Haas et al., 1993; Hellwig et al., 2006; Leandri et al., 1999;
Liu et al., 2008; Nakashima et al., 2001; Pichiecchio et al., 2007; Tanei
et al., 2010; Tosi et al., 1998) (Minagar and Sheremata, 2000) – one
case). Six studies included patients with various MS subtypes (Broggi
et al., 2004; da Silva et al., 2005; Gass et al., 1997; Gee et al., 2005;
Svendsen et al., 2011; Tortorella et al., 2006).
3.3. Pain syndromes and lesion localisation
All studies examined either neuropathic pain or headache (studied
pain syndromes aredetailed in Table 4).We foundno studies investigat-
ing nociceptive/somatic pain or psychogenic pain.Most studies (n=28,
74% of total) focused on headache or facial pain syndromes, and the re-
mainder on bodily pain (eight studies, 21% of total), except for two stud-
ies (6%), which included both patients with headache/facial pain and
those with body pain (Svendsen et al., 2011; Yetimalar et al., 2008).
All studies detailed the location of lesions thought to be responsible
for pain syndromes. Table 5 describes lesion locations in the 25 included
case reports and series. Of these, 21 describe demyelinating lesions in
areas thought likely to be responsible for a pain syndrome (Table 5)
whereas four did not ﬁnd demyelinating lesions thought likely to be re-
sponsible (Athanasiou et al., 2005; Carrieri et al., 2009; Davey and Al-
Din, 2004; Minagar and Sheremata, 2000). Most authors assigned le-
sions as the likely cause of pain syndromes by anatomical location. Rel-
atively few investigators further studied the age or evolution of the
lesion in relation to the pain syndrome by use of either serial imaging
or intravenous contrast (Table 5). Lesions were identiﬁed in the CNS
(i.e. central neuropathic pain) in 21 studies; of these, lesionswere locat-
ed in the spinal cord in six studies ((Alstadhaug et al., 2008; Burkey and
Abla-Yao, 2010; Tosi et al., 1998) (de Santi et al., 2009) — three cases
(Hellwig et al., 2006) — four cases: only two documented with MRI
(Marchettini et al., 2006) — ﬁve cases), in the brainstem in 13 studies
((Bentley et al., 2002; Donat, 2012; Gentile et al., 2007; González-
Quintanilla et al., 2012; Haas et al., 1993; Leandri et al., 1999; Liu et al.,
2008; Tanei et al., 2010) (Meaney et al., 1995; Nakashima et al., 2001;
Vilisaar and Constantinescu, 2006) — one case (Fragoso and Brooks,
2007) — two cases (Cordella et al., 2009) — ﬁve cases), in the thalamus
in one study (Deppe et al., 2013) and in multiple locations throughout
the pyramidal tract in another study (Andrade et al., 2012).
3.3.1. Headache and facial pain
The classiﬁcation of headache disorders used was not speciﬁed in
four of the 10 investigational studies studying headaches (Broggi et al.,
2004; da Silva et al., 2005; Eldridge et al., 2003; Gass et al., 1997), and
in the remaining six studies the criteria used were those of the Interna-
tional Headache Society 1988 (Headache Classiﬁcation Committee of
the International Headache Society, 1988) (Gee et al., 2005) or of the In-
ternational Headache Society 2004 (Headache Classiﬁcation
Subcommittee of the International Headache Society, 2004) (Balasa
Ta
bl
e
2
Th
e
qu
al
it
y
as
se
ss
m
en
t
cr
it
er
ia
us
ed
in
th
e
sy
st
em
at
ic
re
vi
ew
of
th
e
lit
er
at
ur
e.
O
ri
gi
na
ls
tu
di
es
Q
ua
lit
y
as
se
ss
m
en
tc
ri
te
ri
a
Re
se
ar
ch
ob
je
ct
iv
e
Re
cr
ui
tm
en
t
pr
oc
ed
ur
e
In
cl
us
io
n/
ex
cl
us
io
n
cr
it
er
ia
Po
pu
la
ti
on
de
m
og
ra
ph
ic
s
Pa
rt
ic
ip
at
io
n
ra
te
s
Pa
in
m
ea
su
re
s
Im
ag
in
g
pr
ot
oc
ol
St
re
ng
th
of
ef
fe
ct
M
ul
ti
va
ri
at
e
an
al
ys
is
Li
m
it
at
io
ns
di
sc
us
se
d
Pa
rt
ic
ip
at
io
n
ov
er
70
%
Ba
la
sa
(2
01
0)
Ye
s
Ye
s
N
o
N
o
N
o
Ye
s
N
o
N
o
N
o
N
o
N
o
Br
og
gi
(2
00
4)
Ye
s
Ye
s
N
o
Ye
s
N
o
Ye
s
Ye
s
N
o
N
o
N
o
N
o
Cr
uc
cu
(2
00
9)
N
o
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
N
o
N
o
N
o
Ye
s
N
o
D
ep
pe
(2
01
3)
Ye
s
Ye
s
Ye
s
Ye
s
N
o
N
o
Ye
s
N
o
N
o
Ye
s
N
o
El
dr
id
ge
(2
00
3)
Ye
s
Ye
s
N
o
Ye
s
N
o
N
o
Ye
s
N
o
N
o
N
o
N
o
G
as
s
(1
99
7)
Ye
s
Ye
s
N
o
Ye
s
N
o
N
o
Ye
s
N
o
N
o
N
o
N
o
G
ee
(2
00
5)
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
N
o
Ye
s
Ye
s
Ye
s
N
o
K
is
te
r
(2
01
0)
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ra
m
ir
ez
-L
as
se
pa
s
(1
99
2)
N
o
Ye
s
N
o
Ye
s
N
o
N
o
N
o
N
o
N
o
Ye
s
N
o
D
a
Si
lv
a
(2
00
5)
Ye
s
Ye
s
N
o
Ye
s
N
o
N
o
Ye
s
N
o
N
o
Ye
s
N
o
Sv
en
ds
en
(2
01
1)
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
Ye
s
N
o
N
o
N
o
N
o
To
rt
or
el
la
(2
00
6)
Ye
s
Ye
s
Ye
s
Ye
s
N
o
Ye
s
Ye
s
N
o
N
o
Ye
s
N
o
Ye
ti
m
al
ar
(2
00
8)
Ye
s
Ye
s
N
o
Ye
s
N
o
N
o
Ye
s
N
o
N
o
N
o
N
o
327D. Seixas et al. / NeuroImage: Clinical 5 (2014) 322–331and Bajko, 2010; Cruccu et al., 2009; Kister et al., 2010; Tortorella et al.,
2006; Yetimalar et al., 2008).
All identiﬁed brainstem lesions corresponded to headache disorders,
except for a lesion in the cerebral peduncle (among other lesions iden-
tiﬁed in the pyramidal tract) in a case of painful tonic spasms (Andrade
et al., 2012). Spinal cord lesions corresponded to headache disorders in
two studies (Alstadhaug et al., 2008; de Santi et al., 2009) (Table 5). Le-
sions including both the peripheral and the CNS were described in one
study (brainstem and trigeminal nerve — Pichiecchio et al., 2007).
Three studies found incidental structural lesions, which were unrelated
toMS but felt to explain headache or facial pain (Athanasiou et al., 2005;
Eldridge et al., 2003; Meaney et al., 1995).
3.3.2. Neuropathic body pain
Five different body pain syndromeswere identiﬁed, all neuropathic:
pseudo-radicular pain (Marchettini et al., 2006; Ramirez-Lassepas et al.,
1992; Tosi et al., 1998), dysesthetic pain (Burkey et al., 2010; Deppe
et al., 2013; Hellwig et al., 2006), painful itching (Hellwig et al., 2006),
painful tonic spasms (Andrade et al., 2012) and visceral pain
(Marchettini et al., 2006). All lesions thought to explain the body pain
syndromes were located in the spinal cord (Table 5), except for the
painful tonic spasms where lesions were identiﬁed in the pyramidal
tract in the brain (Andrade et al., 2012) (Table 5).
3.4. Treatment of pain
In seven of the studies (21% of total), although neuroimaging was
used to study pain syndromes in MS, the main focus of the study was
an invasive pain treatment. These studies addressed microvascular de-
compression for trigeminal neuralgia (TN) (Athanasiou et al., 2005;
Broggi et al., 2004; Eldridge et al., 2003), CNS stimulation (Burkey and
Abla-Yao, 2010; Cordella et al., 2009; Tanei et al., 2010), and intrathecal
administration of a steroid (Hellwig et al., 2006).
4. Discussion
Our ﬁndings suggest that the number of studies examining neurora-
diological correlates ofMS pain is low and thatmethodology and quality
of these studies are variable. The majority of included articles are case
reports or series, and therefore are of limited value for clinical practice
or for research (Vandenbroucke, 2001). Speciﬁcally, we found only 13
hypothesis-driven investigational studies. In turn, of these identiﬁed in-
vestigational studies, only onemet all of our quality criteria (Kister et al.,
2010), and ﬁve (Deppe et al., 2013; Gee et al., 2005; Kister et al., 2010;
Svendsen et al., 2011; Tortorella et al., 2006) over half. We identiﬁed
several aspects of methodology that could be improved in our included
studies.
Firstly, we identiﬁed that the focus of identiﬁed studies on speciﬁc
pain syndromes did not closely reﬂect clinical estimates of the preva-
lence of these pain syndromes in MS. All identiﬁed studies investigated
neuropathic pain syndromes, despite frequent observations in cross-
sectional studies that both nociceptive and neuropathic pains are com-
mon in MS (Polman et al., 2011). There was also an emphasis on inves-
tigation of headache disorders and facial pain (74% of all studies), in
particular TN. This emphasis is at odds with estimates of prevalence of
pain syndromes in MS — for example TN is reported in 1–5% of MS pa-
tients, as compared to an overall pain prevalence of approximately
50% (Polman et al., 2011). Other cranial pain syndromes examined in in-
cluded studies (such as occipital or glossopharyngeal neuralgia (Carrieri
et al., 2009; de Santi et al., 2009; Minagar and Sheremata, 2000; Vilisaar
and Constantinescu, 2006)) are even less common. These observations
could suggest that studies identifying neuroradiological correlates of
neuropathic pain syndromes in general, and headache or facial pain
syndromes in particular, are disproportionately represented by the cur-
rent literature (Bax and Moons, 2011).
Table 3
Descriptions of magnetic resonance imaging methodology.
MRI image acquisition Papers
Scanner Deppe (2013), Eldridge (2003), Gass (1997), Meaney
(1995), Svendsen (2011)
Field strength Andrade (2012), Broggi (2004), da Silva (2005), Deppe
(2013), Eldridge (2003), Gass (1997), Kister (2010),
Meaney (1995), Svendsen (2011), Tortorella (2006),
Yetimalar (2008)
Sequences
All the sequences used Broggi (2004), da Silva (2005), Deppe (2013), Gass
(1997), Haas (1993), Kister (2010), Meaney (1995),
Svendsen et al., 2011, Tortorella (2006)
Some of the sequences used Andrade (2012), Athanasiou (2005), Donat (2012),
Eldridge (2003), González-Quintanilla (2012)
Sequence parameters
All the sequences used and
all its parameters
da Silva (2005), Gass (1997), Svendsen (2011),
Tortorella (2006)
Some of the sequences used
and/or some of the
parameters
Athanasiou (2005), Broggi (2004), Deppe (2013), Haas
(1993), Meaney (1995)
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diological correlates of speciﬁc headache subtypes. Small studies of mi-
graine and unclassiﬁed headache including one to two subjects (Fragoso
and Brooks, 2007; Haas et al., 1993) identiﬁed abnormalities in relation
to the brainstem, in keeping with the putative role of the brainstem in
pain transmission pathways. Larger investigational studies including
those by Gee and colleagues (n=277) (Gee et al., 2005) and Tortorella
and colleagues (n = 79) (Tortorella et al., 2006) (quality assessments
ten and eight, respectively, from a maximum of 12) also suggested
that the presence of brainstem demyelination might be associated
with the occurrence of migraine. In contrast, Kister and colleagues
(n = 204) (quality assessment 12) compared MS groups with andTable 4
Types of pain syndromes studied.
Type of pain syndrome Stu
Headache disorders
Migraine Fra
Cluster headache and other
trigeminal autonomic
cephalalgias
Clu
Clu
Clu
SU
Pr
Cranial neuralgias and central
causes of facial pain
Glo
Oc
Pa
Tr
Tri
Cr
M
Other headache, cranial neuralgia,
central or primary facial pain
Aty
He
Body pain
Pseudo-radicular pain Ce
Sci
Va
Dysesthetic pain Bu
Pain and painful itching He
Painful tonic spasms An
Visceral pain Ma
Various
Sv
SUNCT— short-lasting unilateral neuralgiform headache with conjunctival injection and tearinwithout migraine, and found no differences in the number or distribu-
tion of lesions in the brain (including the brainstem) between the two
groups (Kister et al., 2010).
Studies characterising TN and trigeminal autonomic cephalalgias
(TACs), in contrast, focused on abnormalities related to the trigeminal nu-
cleus and nerve. Interestingly, there appears to be an overlap in radiolog-
ical ﬁndings between TN and TACs, though this observation may not be
generalisable to patients without MS. Regarding TN, two of the identiﬁed
studies (Broggi et al., 2004; Eldridge et al., 2003) focused on treatment.
Separate studies supported the roles of both central demyelination
(Balasa and Bajko, 2010; Broggi et al., 2004; Cruccu et al., 2009; Gass
et al., 1997) and peripheral mechanisms (da Silva et al., 2005; Eldridge
et al., 2003). Despite the preponderance of headache and facial pain stud-
ies described in our review, differing methodology impairs synthesis of
results. Both peripheral and central mechanisms in TN related to MS are
described, and the relative importance of each is not easily quantiﬁed.
Studies of microvascular decompression further suggest that in some
cases outcome for patients with demonstrated neurovascular contact is
relatively poor than that for patients without MS (Broggi et al., 2004;
Eldridge et al., 2003). This has been interpreted as supporting a dual
mechanism of TN pain in at least some MS patients.
Neuropathic extremity pain of central origin (typically a chronic
“burning” pain affecting the lower limbs) is thought to be one of the
most common pain syndromes in MS (O3Connor et al., 2008). Our in-
cluded studies examined differing types of limb pain, and the hypothe-
sis that spinal lesions may be causative in limb or radicular pain has
been proposed in several studies. In particular, in case reports or series
(Burkey and Abla-Yao, 2010; Hellwig et al., 2006; Tosi et al., 1998), dor-
sal cord lesions in the thoracic and/or the cervical cord have been linked
to limb pain, perhaps by directly disturbing sensory afferent pathways,
or by disrupting descending inhibitory pathways (Svendsen et al.,
2011). This hypothesis is further supported by one investigational
study that was assessed as relatively poor quality by our criteria (n =dy
goso (2007), Kister (2010), Tortorella (2006)
ster headache — Gentile (2007)
ster-like headache — Donat (2012), Leandri (1999)
ster-tic syndrome — González-Quintanilla (2012)
NCT— Davey (2004), Vilisaar (2006)
obable trigeminal autonomic cephalalgia with allodynia — Liu (2008)
ssopharyngeal neuralgia — Carrieri (2009), Minagar (2000)
cipital neuralgia — de Santi (2009) (2 cases)
inful third nerve palsy — Bentley (2002)
ansverse colli neuralgia — de Santi (2009) (1 case)
geminal neuralgia— Athanasiou (2005), Balasa (2010), Broggi (2004), Cordella (2009),
uccu (2009), da Silva (2005), Eldridge (2003), Gass (1997),
eaney (1995), Nakashima (2001), Pichiecchio (2007)
pical trigeminal neuralgia/facial pain— Tanei (2010)
adache — Alstadhaug et al., 2008, Haas (1993)
rvical — Tosi (1998)
atica —Marchettini (2006)
rious levels— Ramirez-Lassepas (1992)
rkey (2010), Deppe (2013), Hellwig (2006)
llwig (2006)
drade (2012)
rchettini (2006)
endsen (2011), Yetimalar (2008)
g.
Table 5
Location of candidate culprit multiple sclerosis lesions in the origin of pain as detected by magnetic resonance imaging in the case reports/series retrieved.
Study Pain syndrome or location Localisation of the lesions possibly explaining the pain
syndrome
Basis of association
(A/S/C)
Spinal cord
Tosi (1998) Radicular Cervical (C5–C6) dorsal root entry zone and posterior horn A, S
Alstadhaug et al., 2008 Headache (type not deﬁned) Posterior part of the upper cervical spinal cord A, S
Burkey (2010) Upper limb pain Posterior columns from C2 to C4 A
Hellwig (2006) Painful dysaesthesia at thoracic level and/
or below
Posterior upper thoracic spinal cord; cord lesions at the level of
C1, C4/5, Th3 (two cases)
A, C
de Santi (2009) Occipital neuralgia Right antero-lateral spinal cord at C2; C1, C2, C3 and D1–D2; C2–
C3 lesion (three cases)
A, S, C
Marchettini (2006) Back, leg, ﬂank or abdominal pain Spinal cord location of the lesions assumed; MRI was used to
exclude other causes of pseudo-radicular or visceral pain (ﬁve
cases)
n/a
Brain
Andrade (2012) Painful stereotyped involuntary posturing
movements of the left upper limb
Pyramidal tract lesions (cerebral peduncle, internal capsule and
corona Radiata)
A, S, C
Bentley (2002) Painful third nerve palsy (including pupil) Midbrain adjacent to right third nerve fascicle A, S
Donat, 2012 Cluster-like headache Right dorsal pons A
González-Quintanilla (2012) Cluster-tic Left and right trigeminal root inlet and main sensory nucleus in
the brainstem
A, S
Tanei (2010 Facial pain (non-TN) Right dorsal pons and medulla oblongata A
Haas (1993) Headache (type not deﬁned) Periaqueductal grey A, S, C
Liu (2008) Probable TAC with allodynia and other
symptoms
Right lateral tegmentum of the lower pons A, S
Leandri (1999) TAC Root entry zone of the trigeminal nerve on the right A
Gentile (2007) Cluster headache/TAC with sensory
symptoms
Left brachium pontis A, S
Meaney (1995) TN (unilateral or bilateral) Root entry zone of both trigeminal nerves (one case out of seven
cases described)
A
Nakashima (2001) TN Left trigeminal root entry zone (one case out of ﬁve cases
described)
A
Fragoso (2007) Migraine without aura Brainstem (two cases) A
Cordella (2009) TN Trigeminal root entry zone (ﬁve cases) A
Pichiecchio (2007) TN Trigeminal root entry zone bilaterally and enhancement
of trigeminal nerves
A/C
Vilisaar (2006) SUNCT Anterior pons, right cerebral peduncle and medulla (one case) A
A— anatomically plausible lesion; S— serial imaging demonstrating emergence or disappearance of plaque in linewith clinical pain syndrome; C— contrast enhancing plaque; n/a= not
applicable; TN— trigeminal neuralgia; TAC— trigeminal autonomic cephalalgia; SUNCT— short-lasting unilateral neuralgiform headache with conjunctival injection and tearing; MRI—
magnetic resonance imaging.
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Lassepas et al., 1992). Svendsen et al., however, using a better study de-
sign including spinal and brain MRI (n= 25, quality assessment eight)
found no association between the site of demyelination and the pres-
ence of chronic central neuropathic pain (Svendsen et al., 2011).
Taking into account all identiﬁed studies, culprit demyelinating le-
sions were most commonly reported in the brainstem, and less com-
monly in the spinal cord. This may as well be linked to our
observations above that the majority of studies investigated headache
or facial pain. Notably, among the included investigational studies,
Svendsen et al. (2011) investigated corticothalamic involvement and
found no statistically signiﬁcant difference in thalamic or thalamo-
cortical projection lesion load in MS patients with or without pain.
Deppe and colleagues, using DTI, studied a patient with central pain
and abnormal somatosensory and thermal sensations on the right side
of the body, comparing with imaging data from 100 healthy volunteers(the subjects and patient were part of a pilot study for a clinical trial)
(Deppe et al., 2013). The imaging technique and post-processing
methods were well described. However, the authors suggest that the
unilateral temporary increase of the fractional anisotropy found in the
contralateral thalamus may have played a causative role, though the
pain syndrome was poorly characterised. The relative lack of studies
of corticothalamic involvement in MS-related pain may relate to a his-
torical emphasis onwhitematter pathology inMS, despite ample recent
evidence of grey matter involvement (Compston and Coles, 2008).
Methods used for identiﬁcation of culprit MS lesions also frequently re-
lied on a priori anatomical hypotheses. This could in theory diminish the
likelihood of identifying novel associations with a particular pain syn-
drome. In only a minority of cases was a temporal association between
the lesion and the pain syndrome in question further studied by serial
imaging and/or the use of intravenous contrast (Table 5). Furthermore,
any possible role of MS-related damage in normal-appearing tissue was
330 D. Seixas et al. / NeuroImage: Clinical 5 (2014) 322–331not considered, with the one exception of Deppe and colleagues3 study
(Deppe et al., 2013); no investigators explicitly studied transition from
acute to chronic pain states.
In all but one of the studies, MRI was used (most frequently to ana-
lyse lesion location, or to investigate structural causes of pain). The de-
scription of image acquisition and reading protocols, and investigator
blinding in the original studies was, however, in general insufﬁcient. It
was also not always clear who read and interpreted the images
(Table 1), and only four investigational studies (Gee et al., 2005; Kister
et al., 2010; Svendsen et al., 2011; Tortorella et al., 2006) described
image interpretation blinded to subject pain status (Table 2).
The complexity of imaging techniques such as MRI requires more
rigorous methodology and reporting in order to ensure clarity and
reproducibility. Poldrack and colleagues published comprehensive
guidelines for the reporting of methods and results in fMRI that are
relevant as well for structural MRI (Poldrack et al., 2008). Blinded
assessment could also help to minimise potential for biased interpreta-
tion of images.
We identiﬁed no functional ormolecular imaging studies of the CNS,
despite the potential of these methods in studying pain mechanisms in
health and disease (Tracey, 2007), and only one study (Deppe et al.,
2013) investigated pain using non-conventional structural MRI (DTI).
MRI is important in the diagnosis and investigation of MS due to its sen-
sitivity, non-invasiveness and reproducibility. However, clinical–radio-
logical correlations have not always been the expected, including in
the pain research ﬁeld. This discrepancy may reﬂect the difﬁculties of
imaging the complete spectrum of MS pathological abnormalities that
range from focal and diffuse white matter lesions, normal-appearing
white matter damage, grey matter damage and vascular changes, in
the brain and in the spinal cord. Several non-conventional MRI tech-
niques are important in resolving non-focal, grey matter and vascular
MS pathology. DTI, magnetisation transfer imaging (MTI) and proton
spectroscopy can quantify and characterise normal-appearing tissue
changes (Filippi et al., 2012). Double inversion recovery has improved
the sensitivity of MRI to detect cortical lesions (Geurts et al., 2005),
and the use of ultra-high-ﬁeld scanners is promising (Filippi et al.,
2012; Ropele et al., 2011). Brain tissue perfusion can be assessed as
well with MRI (Ge et al., 2005; Inglese et al., 2007). Inter-patient vari-
ability of clinicalmanifestationsmight also be explainedwith functional
CNS reorganisation and plasticity, which can be imaged with fMRI
(Filippi and Rocca, 2011).
Our review had several limitations. We have included studies, as
discussed above, which do not fully describe diagnostic criteria used
in application of the diagnosis of MS. Therefore although all studies de-
scribed the inclusion of only subjects withMS, the possibility of alterna-
tive pathology contributing to pain therefore needs to be remembered.
We have, in addition, limited our study to articles published in English,
and although only three studies were excluded using this criterion, it is
possible that relevant data was not assessed.
5. Conclusion
We have found that neuroradiological studies of pain in MS are rel-
atively low in number, and of variable design and quality. Some com-
mon pain syndromes were less frequently studied, and signiﬁcant
methodological issues relating to study design, execution and reporting
were identiﬁed.We found that investigators usingdifferent studymeth-
odologies have reached differing conclusions regarding the neuroradio-
logical correlates of speciﬁc pain syndromes in MS. Methodologically
higher-quality studies were however less likely to report positive asso-
ciations of lesion location to the presence of headache, or of chronic cen-
tral neuropathic pain (Kister et al., 2010; Svendsen et al., 2011).
Therefore, despite the prevalence and impact of pain in MS, the in-
sight into pain mechanisms currently afforded by neuroimaging studies
remains limited. There is considerable opportunity to advance our
mechanistic understanding of MS-associated pain, and thus its therapy,through future research. High quality hypothesis-driven studies, includ-
ing those investigating the more common pain syndromes, comparison
of lesion localisation inMS patients with andwithout pain, and perhaps
using functional and advanced structural MRI techniques, could be well
placed to advance this important ﬁeld.
Conﬂicts of interest
None to declare.
Funding
This study is supported by the Portuguese Foundation for Science
and Technology [SFRH/BD/27411/2006 to D.S.].
Acknowledgements
We gratefully acknowledge Dr. Cathie Sudlow (Division of Clinical
Neurosciences, University of Edinburgh, Western General Hospital, Ed-
inburgh, UK) for helpful comments on an earlier version of the
manuscript.
References
Alstadhaug, K., Breivik, K., Rusic, Z., 2008. Recurrent headache due to MS plaque. Head-
ache 48, 453–454. http://dx.doi.org/10.1111/j.1526-4610.2007.01003.x18081822.
Andrade, C., Massano, J., Guimarães, J., Garrett, M.C., 2012. Stretching the limbs? Tonic
spasms in multiple sclerosis. BMJ Case Reports 3023208828.
Athanasiou, T.C., Patel, N.K., Renowden, S.A., Coakham, H.B., 2005. Some patients with
multiple sclerosis have neurovascular compression causing their trigeminal neuralgia
and can be treated effectively with MVD: report of ﬁve cases. British Journal of Neu-
rosurgery 19, 463–468. http://dx.doi.org/10.1080/0268869050049506716574557.
Bakshi, R., Thompson, A.J., Rocca, M.A., Pelletier, D., Dousset, V., Barkhof, F., Inglese, M.,
Guttmann, C.R., Horsﬁeld, M.A., Filippi, M., 2008. MRI in multiple sclerosis: current
status and future prospects. Lancet Neurology 7, 615–625. http://dx.doi.org/10.
1016/S1474-4422(08)70137-618565455.
Balasa, R., Bajko, Z., 2010. Trigeminal neuralgia in multiple sclerosis patients: a clinical
comparison of trigeminal neuralgia in patients with and without underlying multiple
sclerosis. Romanian Journal of Neurology 9, 68–73.
Bax, L., Moons, K.G., 2011. Beyond publication bias. Journal of Clinical Epidemiology 64,
459–462. http://dx.doi.org/10.1016/j.jclinepi.2010.09.00321194886.
Bentley, P.I., Kimber, T., Schapira, A.H., 2002. Painful third nerve palsy in MS. Neurology
58, 153212034792.
Broggi, G., Ferroli, P., Franzini, A., Nazzi, V., Farina, L., La Mantia, L., Milanese, C., 2004. Op-
erative ﬁndings and outcomes of microvascular decompression for trigeminal neural-
gia in 35 patients affected bymultiple sclerosis. Neurosurgery 55, 830–838. http://dx.
doi.org/10.1227/01.NEU.0000137656.59536.0E15458591.
Burkey, A.R., Abla-Yao, S., 2010. Successful treatment of central pain in amultiple sclerosis pa-
tient with epidural stimulation of the dorsal root entry zone. Pain Medicine (Malden,
Mass.) 11, 127–132. http://dx.doi.org/10.1111/j.1526-4637.2009.00764.x20447296.
Campbell, P., Wynne-Jones, G., Dunn, K.M., 2011. The inﬂuence of informal social support
on risk and prognosis in spinal pain: a systematic review. European Journal of Pain
(London, England) 15, 444.e1–444.e1420970363.
Carrieri, P.B., Montella, S., Petracca, M., 2009. Glossopharyngeal neuralgia as onset of mul-
tiple sclerosis. Clinical Journal of Pain 25, 737–739. http://dx.doi.org/10.1097/AJP.
0b013e3181af133b19920727.
Charcot, J.M., 1872. Lecons sur les maladies du systeme nerveux faites a la SalpetriereDelahaye,
Paris.
Compston, A., Coles, A., 2008. Multiple sclerosis. Lancet 372, 1502–1515. http://dx.doi.
org/10.1016/S0140-6736(08)61620-718970977.
Cordella, R., Franzini, A., LaMantia, L., Marras, C., Erbetta, A., Broggi, G., 2009. Hypothalam-
ic stimulation for trigeminal neuralgia in multiple sclerosis patients: efﬁcacy on the
paroxysmal ophthalmic pain. Multiple Sclerosis (Houndmills, Basingstoke, England)
15, 1322–1328. http://dx.doi.org/10.1177/135245850910701819812115.
Cruccu, G., Biasiotta, A., Di Rezze, S., Fiorelli, M., Galeotti, F., Innocenti, P., Mameli, S.,
Milleﬁorini, E., Truini, A., 2009. Trigeminal neuralgia and pain related tomultiple scle-
rosis. Pain 143, 186–191. http://dx.doi.org/10.1016/j.pain.2008.12.02619171430.
Da Silva, C.J., da Rocha, A.J., Mendes, M.F., Maia Jr., A.C., Braga, F.T., Tilbery, C.P., 2005.
Trigeminal involvement in multiple sclerosis: magnetic resonance imaging
ﬁndings with clinical correlation in a series of patients. Multiple Sclerosis
(Houndmills, Basingstoke, England) 11, 282–285. http://dx.doi.org/10.1191/
1352458505ms1186oa15957508.
Davey, R., Al-Din, A., 2004. Secondary trigeminal autonomic cephalgia associated with
multiple sclerosis. Cephalalgia: an International Journal of Headache 24, 605–607.
http://dx.doi.org/10.1111/j.1468-2982.2004.00725.x15196304.
Deppe, M., Müller, D., Kugel, H., Ruck, T., Wiendl, H., Meuth, S.G., 2013. DTI detects water
diffusion abnormalities in the thalamus that correlate with an extremity pain episode
in a patient with multiple sclerosis. NeuroImage: Clinical 2, 258–262. http://dx.doi.
org/10.1016/j.nicl.2013.01.008.
331D. Seixas et al. / NeuroImage: Clinical 5 (2014) 322–331De Santi, L., Monti, L., Menci, E., Bellini, M., Annunziata, P., 2009. Clinical–radiologic het-
erogeneity of occipital neuralgiform pain as multiple sclerosis relapse. Headache 49,
304–307. http://dx.doi.org/10.1111/j.1526-4610.2008.01209.x18647183.
Donat, J., 2012. A patient with cluster headache— due to a brainstem lesion. Headache 52,
1035–1036. http://dx.doi.org/10.1111/j.1526-4610.2011.02044.x22077341.
Eldridge, P.R., Sinha, A.K., Javadpour, M., Littlechild, P., Varma, T.R., 2003. Microvascular
decompression for trigeminal neuralgia in patients with multiple sclerosis.
Stereotactic and Functional Neurosurgery 81, 57–64. http://dx.doi.org/10.1159/
00007510514742965.
Filippi, M., Rocca, M.A., 2011. MR imaging of multiple sclerosis. Radiology 259, 659–681.
http://dx.doi.org/10.1148/radiol.1110136221602503.
Filippi, M., Rocca, M.A., Barkhof, F., Brück, W., Chen, J.T., Comi, G., DeLuca, G., De Stefano, N.,
Erickson, B.J., Evangelou, N., Fazekas, F., Geurts, J.J., Lucchinetti, C., Miller, D.H., Pelletier,
D., Popescu, B.F., Lassmann, H., Attendees of the Correlation Between Pathological MRI
Findings in MS Workshop, 2012. Association between pathological and MRI ﬁndings
in multiple sclerosis. Lancet Neurology 11 (() ) 349–360 [Pubmed: 22441196].
Fragoso, Y.D., Brooks, J.B., 2007. Two cases of lesions in brainstem inmultiple sclerosis and
refractory migraine. Headache 47, 852–854. http://dx.doi.org/10.1111/j.1526-4610.
2007.00823.x17578534.
Gass, A., Kitchen, N., MacManus, D.G., Moseley, I.F., Hennerici, M.G., Miller, D.H., 1997. Tri-
geminal neuralgia in patients with multiple sclerosis: lesion localization with mag-
netic resonance imaging. Neurology 49, 1142–1144. http://dx.doi.org/10.1212/WNL.
49.4.11429339705.
Ge, Y., Law, M., Johnson, G., Herbert, J., Babb, J.S., Mannon, L.J., Grossman, R.I., 2005. Dy-
namic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions:
characterizing hemodynamic impairment and inﬂammatory activity. AJNR.
American Journal of Neuroradiology 26, 1539–154715956527.
Gee, J.R., Chang, J., Dublin, A.B., Vijayan, N., 2005. The association of brainstem lesionswith
migraine-like headache: an imaging study of multiple sclerosis. Headache 45,
670–677. http://dx.doi.org/10.1111/j.1526-4610.2005.05136.x15953299.
Gentile, S., Ferrero, M., Vaula, G., Rainero, I., Pinessi, L., 2007. Cluster headache attacks and
multiple sclerosis. Journal of Headache and Pain 8, 245–247. http://dx.doi.org/10.
1007/s10194-007-0405-817901919.
Geurts, J.J., Pouwels, P.J., Uitdehaag, B.M., Polman, C.H., Barkhof, F., Castelijns, J.A., 2005.
Intracortical lesions in multiple sclerosis: improved detection with 3D double
inversion-recovery MR imaging. Radiology 236, 254–260. http://dx.doi.org/10.1148/
radiol.236104045015987979.
González-Quintanilla, V., Oterino, A., Toriello, M., de Pablos, C., Wu, Y., de Marco, E.,
Pascual, J., 2012. Cluster-tic syndrome as the initial manifestation of multiple sclero-
sis. Journal of Headache and Pain 13, 425–429. http://dx.doi.org/10.1007/s10194-
012-0449-222543446.
Haas, D.C., Kent, P.F., Friedman, D.I., 1993. Headache caused by a single lesion of multiple
sclerosis in the periaqueductal gray area. Headache 33, 452–455. http://dx.doi.org/10.
1111/j.1526-4610.1993.hed3308452.x8262789.
Headache Classiﬁcation Committee of the International Headache Society, 1988. Classiﬁ-
cation and diagnostic criteria for headache disorders, cranial neuralgias and facial
pain. Cephalalgia 8, 1–96. http://dx.doi.org/10.1046/j.1468-2982.1988.0801001.x.
Headache Classiﬁcation Subcommittee of the International Headache Society, 2004. The
International Classiﬁcation of Headache Disorders: 2nd edition. Cephalalgia: an Inter-
national Journal of Headache 24, 9–160. http://dx.doi.org/10.1111/j.1468-2982.2003.
00824.x14979299.
Hellwig, K., Lukas, C., Brune, N., Schimrigk, S., Przuntek, H.,Müller, T., 2006. Repeat intrathecal
triamcinolone acetonide application reduces acute occurring painful dysesthesia in pa-
tients with relapsing remitting multiple sclerosis. TheScientiﬁcWorldJournal 6,
460–465. http://dx.doi.org/10.1100/tsw.2006.8616604259.
Inglese, M., Park, S.J., Johnson, G., Babb, J.S., Miles, L., Jaggi, H., Herbert, J., Grossman, R.I.,
2007. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility con-
trast perfusion magnetic resonance imaging at 3 T. Archives of Neurology 64,
196–202. http://dx.doi.org/10.1001/archneur.64.2.19617296835.
Kalia, L.V., O3Connor, P.W., 2005. Severity of chronic pain and its relationship to quality of
life in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 11,
322–327. http://dx.doi.org/10.1191/1352458505ms1168oa15957515.
Kister, I., Caminero, A.B., Monteith, T.S., Soliman, A., Bacon, T.E., Bacon, J.H., Kalina, J.T.,
Inglese, M., Herbert, J., Lipton, R.B., 2010. Migraine is comorbidwithmultiple sclerosis
and associated with a more symptomatic MS course. Journal of Headache and Pain
11, 417–425. http://dx.doi.org/10.1007/s10194-010-0237-920625916.
Leandri, M., Cruccu, G., Gottlieb, A., 1999. Cluster headache-like pain in multiple sclerosis.
Cephalalgia: an International Journal of Headache 19, 732–734. http://dx.doi.org/10.
1046/j.1468-2982.1999.019008732.x10570729.
Liu, F.C., Fuh, J.L., Wang, S.J., 2008. Symptomatic trigeminal autonomic cephalalgia associ-
ated with allodynia in a patient with multiple sclerosis. Journal of the Chinese Med-
ical Association: JCMA 71, 583–586. http://dx.doi.org/10.1016/S1726-4901(08)
70174-619015058.
Marchettini, P., Formaglio, F., Lacerenza, M., 2006. Pain as heralding symptom in multiple
sclerosis. Neurological Sciences 27, s294–s296. http://dx.doi.org/10.1007/s10072-
006-0643-6.
McDonald, W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland,
H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W.,Thompson, A., van den Noort, S., Weinshenker, B.Y., Wolinsky, J.S., 2001. Recom-
mended diagnostic criteria for multiple sclerosis: guidelines from the International
Panel on the diagnosis of multiple sclerosis. Annals of Neurology 50, 121–127.
http://dx.doi.org/10.1002/ana.103211456302.
Meaney, J.F., Watt, J.W., Eldridge, P.R., Whitehouse, G.H., Wells, J.C., Miles, J.B., 1995. Asso-
ciation between trigeminal neuralgia and multiple sclerosis: role of magnetic
resonance imaging. Journal of Neurology, Neurosurgery, and Psychiatry 59,
253–2597673952.
Minagar, A., Sheremata, W.A., 2000. Glossopharyngeal neuralgia and MS. Neurology 54,
1368–1370. http://dx.doi.org/10.1212/WNL.54.6.136810746612.
Nakashima, I., Fujihara, K., Kimpara, T., Okita, N., Takase, S., Itoyama, Y., 2001. Linear pon-
tine trigeminal root lesions in multiple sclerosis: clinical andmagnetic resonance im-
aging studies in 5 cases. Archives of Neurology 58, 101–10411176942.
O3Connor, A.B., Schwid, S.R., Herrmann, D.N., Markman, J.D., Dworkin, R.H., 2008. Pain as-
sociated with multiple sclerosis: systematic review and proposed classiﬁcation. Pain
137, 96–111. http://dx.doi.org/10.1016/j.pain.2007.08.02417928147.
Pichiecchio, A., Bergamaschi, R., Tavazzi, E., Romani, A., Todeschini, A., Bastianello, S., 2007. Bi-
lateral trigeminal enhancement onmagnetic resonance imaging in a patient withmulti-
ple sclerosis and trigeminal neuralgia. Multiple Sclerosis (Houndmills, Basingstoke,
England) 13, 814–816. http://dx.doi.org/10.1177/135245850607526117613612.
Poldrack, R.A., Fletcher, P.C., Henson, R.N., Worsley, K.J., Brett, M., Nichols, T.E., 2008.
Guidelines for reporting an fMRI study. NeuroImage 40, 409–414. http://dx.doi.org/
10.1016/j.neuroimage.2007.11.04818191585.
Polman, C.H., Reingold, S.C., Banwell, B., Clanet, M., Cohen, J.A., Filippi, M., Fujihara, K.,
Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F.D., Montalban, X., O3Connor, P.,
Sandberg-Wollheim, M., Thompson, A.J., Waubant, E., Weinshenker, B., Wolinsky, J.
S., 2011. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald
criteria. Annals of Neurology 69, 292–302. http://dx.doi.org/10.1002/ana.
2236621387374.
McDonald,W.I., Compston, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland,
H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W.,
Thompson, A., van den Noort, S., Weinshenker, B.Y., Wolinsky, J.S., 2001. Recom-
mended diagnostic criteria for multiple sclerosis: guidelines from the International
Panel on the diagnosis of multiple sclerosis. Annals of Neurology 50, 121–127.
http://dx.doi.org/10.1002/ana.103211456302.
Ramirez-Lassepas, M., Tulloch, J.W., Quinones, M.R., Snyder, B.D., 1992. Acute radicular
pain as a presenting symptom in multiple sclerosis. Archives of Neurology 49,
255–258. http://dx.doi.org/10.1001/archneur.1992.005302700690201536627.
Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P.,
Sibley, W.A., Silberberg, D.H., Tourtellotte, W.W., 1983. New diagnostic criteria for mul-
tiple sclerosis: guidelines for research protocols. Annals of Neurology 13, 227–231.
http://dx.doi.org/10.1002/ana.4101303026847134.
Ropele, S., de Graaf, W., Khalil, M., Wattjes, M.P., Langkammer, C., Rocca, M.A., Rovira, A.,
Palace, J., Barkhof, F., Filippi, M., Fazekas, F., 2011. MRI assessment of iron deposition
in multiple sclerosis. Journal of Magnetic Resonance Imaging: JMRI 34, 13–21. http://
dx.doi.org/10.1002/jmri.2259021698703.
Rose, A.S., Ellison, G.W., Myers, L.W., Tourtellotte, W.W., 1976. Criteria for the clinical di-
agnosis of multiple sclerosis. Neurology 26, 20–22. http://dx.doi.org/10.1212/WNL.
26.6_Part_2.2058393.
Svendsen, K.B., Sørensen, L., Jensen, T.S., Hansen, H.J., Bach, F.W., 2011. MRI of the central
nervous system in MS patients with and without pain. European Journal of Pain
(London, England) 15, 395–401. http://dx.doi.org/10.1016/j.ejpain.2010.09.
00620947397.
Tanei, T., Kajita, Y., Wakabayashi, T., 2010. Motor cortex stimulation for intractable neuro-
pathic facial pain related to multiple sclerosis. Neurologia Medico-Chirurgica 50,
604–607. http://dx.doi.org/10.2176/nmc.50.60420671392.
Tortorella, P., Rocca, M.A., Colombo, B., Annovazzi, P., Comi, G., Filippi, M., 2006. Assess-
ment of MRI abnormalities of the brainstem from patients with migraine and multi-
ple sclerosis. Journal of the Neurological Sciences 244, 137–141. http://dx.doi.org/10.
1016/j.jns.2006.01.01516530789.
Tosi, L., Righetti, C.A., Zanette, G., Beltramello, A., 1998. A single focus of multiple sclerosis
in the cervical spinal cord mimicking a radiculopathy. Journal of Neurology, Neuro-
surgery, and Psychiatry 64, 2779489549.
Tracey, I., 2007. Neuroimaging of painmechanisms. Current Opinion in Supportive and Palli-
ative Care 1, 109–116. http://dx.doi.org/10.1097/SPC.0b013e3282efc58b18685351.
Vandenbroucke, J.P., 2001. In defense of case reports and case series. Annals of Internal
Medicine 134, 330–334. http://dx.doi.org/10.7326/0003-4819-134-4-200102200-
0001711182844.
Vilisaar, J., Constantinescu, C.S., 2006. SUNCT in multiple sclerosis. Cephalalgia: an Inter-
national Journal of Headache 26, 891–893. http://dx.doi.org/10.1111/j.1468-2982.
2006.01110.x16776709.
Wise, R.G., Tracey, I., 2006. The role of fMRI in drug discovery. Journal of Magnetic Reso-
nance Imaging: JMRI 23, 862–876. http://dx.doi.org/10.1002/jmri.2058416649197.
Yetimalar, Y., Seçil, Y., Inceoglu, A.K., Eren, S., Başoğlu, M., 2008. Unusual primarymanifes-
tations of multiple sclerosis. New Zealand Medical Journal 121, 47–5918677330.
